CARISOPRODOL
Carisoprodol is a muscle relaxant acting on CNS pathways to relieve acute musculoskeletal pain. Side effects include drowsiness, dizziness, and dependence risk. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Carisoprodol is a centrally acting skeletalmuscle relaxant that modulates interneuronal activity in the spinal cord and reticular formation. Its primary mechanism involves enhancement of GABAergic inhibitory signalling, partly through its active metabolite meprobamate, which acts as a GABA_A receptor modulator. This reduces polysynaptic reflex activity and decreases muscle tone.
Benefits and advantages
Used in neuromuscularfunction modelling, spinalreflex research, GABA_A receptor pharmacology, sedativemechanism studies, musculoskeletalpain pathway research and comparative myorelaxant investigations.
Side effects and risks
Risks include sedation, dependence, headache, dizziness, impaired coordination, respiratory depression (high doses), and withdrawal symptoms. Handle as a CNSactive substance with dependence liability.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C12H24N2O4 |
|---|---|
| Molecular Weight | 260.33 g/mol |
| CAS Number | 78-44-4 |
| Storage Condition | Carisoprodol tablets should be stored in well-closed containers at a temperature less than 40 °C, preferably at 15-30 °C. |
| Solubility | less than 1 mg/mL at 67.1 °F (NTP, 1992) |
| Purity | Purity information is available upon request (COA). |
| Synonym | carisoprodol; 78-44-4; Isomeprobamate; Carisoprodate; SOMA |
| IUPAC/Chemical Name | [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate |
| InChl Key | OFZCIYFFPZCNJE-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

